In DILI, FXR plays a significant regulatory role in bile acid and cholesterol production and metabolism.[42] Various FXR agonists, such as GW4064 and OCA, have been used in the treatment of metabolic diseases. This evidence concerns the gene NR1H4 and metabolic disease.